Evaluation of the Reliability, Validity, and Acceptability of the London Measure of Unplanned Pregnancy in a U.S. Population of Women (LMUP)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00306007
First received: March 17, 2006
Last updated: June 23, 2013
Last verified: June 2013
  Purpose

The aim of the study is to evaluate the reliability, validity, and acceptability of the London Measure of Unplanned Pregnancy (LMUP) in a U.S. population of women. The researchers hypothesize that the LMUP will be acceptable to a U.S. population and will be reliable and valid.


Condition Phase
Unplanned Pregnancy
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of the Reliability, Validity, and Acceptability of the London Measure of Unplanned Pregnancy in a U.S. Population of Women

Further study details as provided by University of California, San Francisco:

Enrollment: 320
Study Start Date: November 2005
Study Completion Date: August 2007
Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
English prenatal
English speaking women recruited from the general OB/GYN clinic
Spanish prenatal
Spanish speaking (monolingual) women recruited from the general OB/GYN clinic
English abortion clinic
English speaking women recruited from the abortion clinic
Spanish abortion clinic
Spanish speaking (monolingual) women recruited from the abortion clinic

Detailed Description:

The concept of "unplanned pregnancy" is used frequently in health research and policy. The majority of tools used to assess unplanned pregnancy planning have not been validated. Recently the London Measure of Unplanned Pregnancy (LMUP) has been developed and validated. The LMUP had been found to be valid and reproducible, but has not been studied outside of the United Kingdom. If we are able to validate this measure in a U.S. population, its use in studies will improve the quality of data about family planning in U.S. women.

  Eligibility

Ages Eligible for Study:   15 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

target population for this study is pregnant women who present to san Francisco General Hospital (SFGH) Women's Options Center (WOC) for abortion and to the Women's Health Center for prenatal care. The population is racially and ethnically diverse, and the majority are financially challenged and have no insurance or Medicaid.

Criteria

Inclusion Criteria:

  • Pregnant women
  • Basic literacy in English or Spanish needed to participate.

Exclusion Criteria:

  • Literacy level lower than 11 years of age
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00306007

Locations
United States, California
San Francisco General Hospital
San Francisco, California, United States, 94110
Sponsors and Collaborators
University of California, San Francisco
Investigators
Principal Investigator: Jody Steinauer, MD, MAS University of California, San Francisco
Study Director: Diane Morof, MD, MSc University of California, San Francisco
  More Information

No publications provided

Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT00306007     History of Changes
Other Study ID Numbers: H1179-27236-01A
Study First Received: March 17, 2006
Last Updated: June 23, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, San Francisco:
Pregnancy
Unplanned pregnancy
Psychosocial
Measure

ClinicalTrials.gov processed this record on April 15, 2014